Immatics Biotechnologies GmbH - Company Profile

Powered by

All the sales intelligence you need on Immatics Biotechnologies GmbH in one solution.

$ $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Immatics Biotechnologies GmbH fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Immatics Biotechnologies GmbH.

Back to companies

Immatics Biotechnologies GmbH: Patents

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

View up-to-date information on Immatics Biotechnologies GmbH patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
US11833195B2 Grant Amidated peptides and their deamidated counterparts displayed by hla-a*02 for use in immunotherapy against different types of cancers A61K2039/5158; A61K39/00; A61K39/0011; A61P35/00; C07K14/705; C07K14/70539 December 05, 2023
US11833193B2 Grant A*03 restricted peptides for use in immunotherapy against cancers and related methods A61K2039/5158; A61K39/0011; A61P35/00; C07K16/2833; C07K16/30; C07K2317/32; C07K7/06 December 05, 2023
US11833194B2 Grant Peptides and combination of peptides for use in immunotherapy against various cancers C12N15/115; C12N2310/16; C12N2502/11; C12N5/0636; C12N5/0638; C12N9/0091; C12N9/1264; C12Q1/6886; C12Q2600/156; C12Y116/01; C12Y207/07031; A61K2039/5158; A61K2039/572; A61K35/17; A61K38/00; A61K39/0011; C07K14/47; C07K14/4748; C07K14/705; C07K14/7051; C07K14/71; C07K14/721; C07K14/8135; C07K16/18; C07K16/28; C07K16/2863; C07K16/2869; C07K16/30; C07K16/38; C07K16/40; C07K2317/34; C07K2317/76; C07K2319/40; C07K7/06; C07K7/08; G01N2333/47; G01N33/57484; G16B25/00; G16B25/10 December 05, 2023
US20230382963A1 Application B*44 restricted peptides for use in immunotherapy against cancers and related methods C12N5/0636; C12Q1/6886; A61K35/17; A61K39/0011; C07K14/4748; C07K14/7051; C07K14/70539; C07K16/18; G16B25/10 November 30, 2023
US20230382964A1 Application Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc, sclc and other cancers C12N15/1062; C12N15/115; C12N5/0638; A61K2039/5158; A61K2039/572; A61K35/17; A61K38/00; A61K39/0011; A61K39/001102; A61P35/00; C07K14/4748; C07K14/5434; C07K14/7051; C07K14/70539; C07K16/2818; C07K16/30; C07K7/06; G01N33/57492 November 30, 2023
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Learn more

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer